Insider Trading November 21, 2026 07:45 PM

Filana Therapeutics CEO Barry Richard Purchases $206,896 in Company Stock

The buy comes as the stock has surged over 50% in the past week but remains down 78% over the past year.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
FLNA

Barry Richard, President and CEO of Filana Therapeutics, purchased 440,206 shares of company stock on November 16, 2026, at a weighted average price of $0.47 per share, for a total value of $206,896. The stock has since risen over 50% to $0.64 but is still down 78% over the past year. Following the purchase, Richard indirectly beneficially owns 1,778,170 shares through a trust. In separate news, the Fifth Circuit vacated class certification in a securities class action against the company, citing misapplication of the legal standard and failure to adequately consider meme-stock dynamics.

Filana Therapeutics CEO Barry Richard Purchases $206,896 in Company Stock
FLNA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Barry Richard bought 440,206 shares at a weighted average price of $0.47, totaling $206,896, and indirectly owns 1,778,170 shares through a trust.
  • The stock has jumped over 50% in the past week to $0.64 but is still down 78% over the past year.
  • The Fifth Circuit vacated class certification in a securities class action against Filana, citing errors in evaluating market efficiency and meme-stock dynamics.

Filana Therapeutics, Inc. (NASDAQ:FLNA) disclosed that its President and Chief Executive Officer, Barry Richard, acquired 440,206 shares of the company's common stock on November 16, 2026. The total value of the transactions was $206,896, according to a Form 4 filing signed by Eric J. Schoen by Power of Attorney on November 18, 2026.

The shares were purchased at a weighted average price of $0.47 per share, with individual transaction prices ranging from $0.45 to $0.48. The timing of the purchase proved fortuitous, as the stock has since surged over 50% in the past week to trade at $0.64. Despite this recent gain, the stock remains down 78% over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels, with additional insights available through the platform's comprehensive Fair Value assessment and over 10 additional ProTips for FLNA investors.

Following these purchases, Mr. Richard indirectly beneficially owns 1,778,170 shares of Filana Therapeutics common stock through a trust.

In other recent developments, the United States Court of Appeals for the Fifth Circuit has vacated the class certification in a securities class action against Filana Therapeutics. This decision overturns a previous order by the U.S. District Court for the Western District of Texas. The appellate court agreed with Filana Therapeutics' position that the District Court misapplied the legal standard for certifying the class. Specifically, the court found that the evidence related to market inefficiency was not properly evaluated. Additionally, the Fifth Circuit noted that the District Court did not adequately consider the defendants' argument regarding meme-stock dynamics affecting the company's securities. This development was disclosed in a filing with the Securities and Exchange Commission.

These recent developments could impact the ongoing litigation against Filana Therapeutics. The stock closed at $0.6413 on November 20, up $0.0813 or 14.52%, and traded at $0.6277 after hours, down $0.0136 or 2.12%.

Risks

  • The stock remains highly volatile, with a 78% decline over the past year despite the recent 50% weekly gain.
  • The vacated class certification could be appealed or lead to further litigation, creating ongoing legal uncertainty for the company.
  • The mention of meme-stock dynamics suggests that the stock price may be influenced by retail trading sentiment rather than fundamentals.

More from Insider Trading

Barings Global Fund President Adds 1,000 Shares Near 52-Week Low Nov 21, 2026 Texas Community Bancshares COO Haskell Strange Offloads $14,911 in Stock Nov 21, 2026 Amphastar CFO Offloads $330K in Shares Under Pre-Set Trading Plan Nov 21, 2026 Park-Ohio CFO Offloads $99,213 in Stock Under Pre-Arranged Plan Nov 21, 2026 Regeneron EVP Marion McCourt Offloads $543,504 in Stock Under Prearranged Plan Nov 21, 2026